ASI Life Sciences Introduces Disposable Heat Exchanger and Mixer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ASI Life Sciences Introduces Disposable Heat Exchanger and Mixer


ASI–Life Sciences introduced the DHX Disposable Heat Exchanger and the imPULSE MDS mixing, docking, and shipping system for single-use biopharmaceutical processes.

The DHX Heat Exchanger is a modular system based on the widely accepted industry-standard plate-and-frame design that uses bags to create a sterile fluid path. These bags fit tightly between five stainless-steel plates. The process fluid flows through the single-use bags, while the heating or cooling fluid runs in a counter-current flow through the plates in a completely isolated fluid path. Dimpled jacketing on the plates helps to create a turbulent flow and maximizes heat transfer.

A new mixer will also be introduced as part of ASI’s imPULSE Single-Use Mixing line. The imPULSE MDS has all the same attributes of the traditional imPULSE line including the patented mixing disc that provides thorough mixing throughout the vessel but has been designed as a docking/mixing system with a shippable mixing vessel.

Source: ASI–Life Sciences

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here